Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Multi-Parametric Optimization of Software Quantification for SPECT Dopamine Transporter Imaging | Contract | $33,156.00 | Clinical Trial | Phillip Kuo | Medical Imaging | GE Healthcare | 08/2020 |
| Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms | Contract | $194,732.72 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | BioVentrix, Inc. | 08/2020 |
| CREON (Pancrelipase) Therapy for Subjects with Exocrine Pancreatic Insufficiency (EPI) due to Pancreatic Cancer: A Double-Blind, Randomized, Parallel Design with 2 Dose Cohorts of Pancrelipase... | Contract | $117,787.55 | Clinical Trial | Jen-Jung Pan | COM Phx Internal Medicine | AbbVie Incorporated | 08/2020 |
| COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) | Contract | $1,222,500.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | University of Michigan | 08/2020 |
| A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid | Contract | $503,260.68 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Pharmaceutical Research Associates | 08/2020 |
| A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness | Contract | $1,206,499.00 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Eli Lilly and Company | 08/2020 |
| A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... | Contract | $100,897.00 | Clinical Trial | Setsuko Chambers | Cancer Center Division | GOG Foundation, Inc. | 08/2020 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... | Contract | $1,278,228.50 | Clinical Trial | Charles Hsu | Radiation Oncology | Astrazeneca | 08/2020 |
| A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) | Contract | $607,532.16 | Clinical Trial | Sachin Chaudhary | Medicine | Covance, Incorporated | 08/2020 |
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. | Contract | $168,927.92 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Kinevant Sciences, Inc. | 08/2020 |
| Wireless Transmission of Strain Gauge Measurements | Grant | $460.50 | Research Training | David Margolis | Orthopaedic Surgery | Arizona State University | 07/2020 |
| WAESO: Genotyping Families with Primary Lymphedema | Grant | $460.50 | Research Training | Marlys Witte | Surgery | Arizona State University | 07/2020 |
| WAESO: Exercised Sheep Loading and Motion Analysis | Grant | $460.50 | Research Training | John Szivek | Orthopaedic Surgery | Arizona State University | 07/2020 |
| Smooth Muscle Invasion Selects for Aggressive Prostate Cancer | Fellowship | $174,728.00 | Research Training | Kendra Marr | Cellular & Molecular Medicine | National Cancer Institute | 07/2020 |
| In-situ Reduction in Intravascular Thrombosis Using a Multivalent Vascular Injury Targeting Antithrombotic Conjugate | Grant | $135,352.00 | Research Training | Kyle Koss | Surgery | American Heart Association, Incorporated | 07/2020 |
| Cross Sectional Analysis of Exercised Sheep's Femora (WAESO) | Grant | $460.50 | Research Training | John Szivek | Orthopaedic Surgery | Arizona State University | 07/2020 |
| Weston Brain Institute 2020 Advisor Support Agreement | Grant | $14,135.90 | Research | Pierre Tariot | COM Phx Psychiatry | Weston Brain Institute (Canada) | 07/2020 |
| Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults | Grant | $3,845,912.00 | Research | Elizabeth Connick | Medicine | National Institute on Drug Abuse | 07/2020 |
| Uncovering the Circulating Factor in FSGS | Contract | $60,835.00 | Research | Jason Wertheim | Surgery | Northwestern University | 07/2020 |
| Translational Regulation During Cigarette Smoking-Induced Reprogramming of the tRNA Epitranscriptome, in Vitro and in a Mouse Smoking Model | Grant | $230,250.00 | Research | Xinxin Ding | Pharmacology and Toxicology | State University of New York Research Foundation | 07/2020 |
| Third Renewal of the Intergovernmental Agreement between The City of Tucson and The Arizona Board of Regents | Contract | $88,000.00 | Research | Kelly Reynolds | Community Environment & Policy | City of Tucson, Arizona | 07/2020 |
| Space-based Paper Microfluidic Vertical Flow Assay for Rapid Multiplex Diagnostics (VFD) in COVID-19 Pandemic Response and Recovery | Cooperative Agreement | $149,958.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | Baylor College of Medicine | 07/2020 |
| Role of Endothelial Fatty Acid Binding Proteins in the Pathogenesis of PAH | Grant | $231,000.00 | Research | Zhiyu Dai | COM Phx Internal Medicine | American Heart Association, Incorporated | 07/2020 |
| Repairing the Kidney Endothelium via Targeted Extracellular Matrix Modifiers | Grant | $921,000.00 | Research | Jason Wertheim | Surgery | National Institute of Diabetes and Digestive and Kidney Diseases | 07/2020 |
| Regulation of P-Body Formation and mRNA Decapping in Cancer: Control by AKT and Pim Kinase Phosphorylation of EDC3 | Grant | $394,690.00 | Research | Andrew Kraft | Cancer Center Division | National Cancer Institute | 07/2020 |